Pfizer’s Own 2021 Document Just Dropped a Bombshell List of Over 1,200 Reported Harms — And Millions Are Still Paying the Price in 2026
It’s been five years since that internal Pfizer report — the one they never wanted public anytime soon — first saw daylight. Titled 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports of PF-07302048 (BNT162b2) received through 28-FEB-2021, it was Pfizer’s own Worldwide Safety team compiling 42,086 case reports of adverse events in the first three months after rollout.
Inside Appendix 1 sat a nine-page list of 1,291 Adverse Events of Special Interest (AESIs) they flagged for monitoring. The list spans a wide spectrum of conditions — including:
- Blood clots
- Acute kidney injury
- Cardiac arrest
- Myocarditis and pericarditis
- Neurological events (e.g. facial paralysis)
- Pregnancy-related complications (e.g. fetal distress, stillbirth)
- Multisystem inflammatory syndrome
- Neonatal complications
And many more.
Let’s be clear: this wasn’t internet speculation. It was Pfizer’s own internal pharmacovigilance report.
But there’s a critical distinction that often gets blurred:
These were reported events — not confirmed causal outcomes.
Pfizer explicitly states these are raw, voluntary reports collected after rollout. That means:
- They do not prove the vaccine caused the event
- Some may be coincidental or linked to underlying conditions
- Reporting systems cast a wide net by design to detect possible signals
That’s standard practice in post-marketing safety monitoring. It’s how early warning systems work.
The FOIA Fight That Forced Disclosure
Pfizer and the FDA initially proposed a slow release timeline — widely reported as extending decades. That triggered legal action.
A group called Public Health and Medical Professionals for Transparency pursued access via FOIA. A federal judge ordered an accelerated release schedule, and thousands of pages of documents — including this report — were made public in stages beginning in 2022.
So no — the document didn’t “just drop.”
It was released earlier, after legal pressure forced transparency.
What The Data Actually Means
This is where things either get handled honestly… or get completely distorted.
Post-marketing surveillance systems (like Pfizer’s internal database or public systems such as VAERS) are designed to:
- Capture any event after vaccination
- Identify patterns that might indicate a real safety signal
- Trigger further investigation
They are not designed to establish causation on their own.
However — and this part matters — large volumes of reports can:
- Highlight patterns worth investigating
- Lead to confirmed risks over time
That’s exactly what happened with some conditions.
What Has Been Confirmed Since
Over the past few years, independent studies and regulatory reviews have identified rare but real risks, including:
- Myocarditis and pericarditis, particularly in younger males after mRNA doses
- Typically rare, but documented across multiple countries
- Most cases are mild, though some require hospital care
These findings were eventually acknowledged by regulators globally and reflected in updated guidance.
Where The Debate Gets Messy
There are two extremes that both miss the mark:
On one side:
“Everything in that list was caused by the vaccine.”
That’s not supported by evidence.
On the other:
“The list means nothing at all.”
Also not true.
The reality sits in the uncomfortable middle:
- The report shows what was being monitored early on
- It reflects uncertainty during rapid global rollout
- It includes both noise and potential signals
Some signals turned into confirmed risks.
Most did not.
The Human Impact
Even when risks are rare, they’re not meaningless to the people affected.
Some individuals experienced:
- Cardiac inflammation
- Ongoing symptoms post-event
- Disruption to work and daily life
For those people, statistics don’t soften the impact.
That doesn’t mean the overall risk profile is high — but it does mean individual outcomes matter, and dismissing them outright erodes trust.
Risk–Benefit Still Matters
A key piece often skipped entirely:
During peak pandemic waves, evidence showed vaccines:
- Reduced severe illness and hospitalisation, especially in high-risk groups
- Helped protect healthcare systems under pressure
But that doesn’t automatically mean the balance was identical for every demographic group.
That’s where much of the ongoing debate sits: Was the risk–benefit communicated clearly for everyone?
What This Actually Shows
This document doesn’t prove a hidden catastrophe.
And it doesn’t prove everything was perfectly handled either.
What it does show is:
- Early safety monitoring was broad and cautious
- Large volumes of reports were being tracked from the start
- Transparency came later than many people were comfortable with
And that last point is where trust took a hit.
Bottom Line
- The report is real
- The numbers are real
- The interpretation requires context
Raw reports are not the same as confirmed harm — but they’re also not meaningless.
If there’s one takeaway that actually holds up:
Transparency early beats damage control later. Every time.
Leave a Reply